drugset

drugset / Trial / NCT01825759

Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

NCT01825759 ↗

Phase 4 Unknown 200 enrolled West China Hospital

NaSingle-groupOpen-labelTreatment

Summary

The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension

Timeline

Start: 2013-01
Primary completion: 2014-12
Completion: 2014-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Danshen Dripping Pill	Unknown	27 mg	Oral

Indications